0.075 USD
3.46 B USD
21.21 B USD
About Danaher Corporation
Sector
Industry
CEO
Rainer M. Blair
Website
Headquarters
Washington
Founded
1984
ISIN
AR0002457668
FIGI
BBG01Q2RQWK8
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Related stocks
D
US23291KAK1
DH Europe Finance II SARL 3.4% 15-NOV-2049Yield to maturity
5.42%
Maturity date
Nov 15, 2049
D
US23291KAJ4
DH Europe Finance II SARL 3.25% 15-NOV-2039Yield to maturity
5.10%
Maturity date
Nov 15, 2039
D
XS205114955
DH Europe Finance II SARL 1.8% 18-SEP-2049Yield to maturity
4.29%
Maturity date
Sep 18, 2049
D
DHR4906001
DH Europe Finance II SARL 2.6% 15-NOV-2029Yield to maturity
4.15%
Maturity date
Nov 15, 2029
D
XS205040617
DH Europe Finance II SARL 1.35% 18-SEP-2039Yield to maturity
3.86%
Maturity date
Sep 18, 2039
XS205040609
DH Europe Finance II SARL 0.75% 18-SEP-2031Yield to maturity
3.14%
Maturity date
Sep 18, 2031
D
XS205040480
DH Europe Finance II SARL 0.45% 18-MAR-2028Yield to maturity
2.53%
Maturity date
Mar 18, 2028
See all DHRC bonds
Curated watchlists where DHRC is featured.